Cargando…

Usefulness of Flow Cytometric Analysis for Detecting Leptomeningeal Diseases in Non-Hodgkin Lymphoma

BACKGROUND: The clinical usefulness of flow cytometry (FCM) for the diagnosis of leptomeningeal diseases (LMD) in non-Hodgkin lymphomas has been suggested in previous studies but needs to be further validated. With this regards, we evaluated the use of FCM for LMD in a series of Korean patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Sang-Yong, Lee, Seung-Tae, Kim, Hee-Jin, Oh, Young Lyun, Kim, Seok Jin, Kim, Won Seog, Kim, Sun-Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Laboratory Medicine 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773260/ https://www.ncbi.nlm.nih.gov/pubmed/26915608 http://dx.doi.org/10.3343/alm.2016.36.3.209

Ejemplares similares

Detection of MYD88 L265P in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia and other B-cell non-Hodgkin lymphomas
por: Shin, Sang-Yong, et al.
Publicado: (2016)

Flow Cytometric Analysis of T Cells in Hemophagocytic Lymphohistiocytosis
por: Park, Min-Seung, et al.
Publicado: (2019)

Bone Marrow Flow Cytometry in Staging of Patients With B-cell Non-Hodgkin Lymphoma
por: Kim, Borahm, et al.
Publicado: (2015)

Flow Cytometric Detection of the Classical Hodgkin Lymphoma: Clinical and Research Applications
por: Roshal, Mikhail, et al.
Publicado: (2011)

Risk of non-Hodgkin lymphoma in breast cancer survivors: a nationwide cohort study
por: Kang, Danbee, et al.
Publicado: (2021)

Immune checkpoint inhibitors in patients with pretreated HodgkinÊs lymphoma: a Korean single-center, retrospective study
por: Hur, Joon Young, et al.
Publicado: (2020)

Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma
por: Kim, Seok Jin, et al.
Publicado: (2019)

Flow cytometric light chain analysis of peripheral blood lymphocytes in patients with non-Hodgkin's lymphoma.
por: Johnson, A., et al.
Publicado: (1985)

Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing
por: Cho, Junhun, et al.
Publicado: (2021)

A Case of Coincident Multiple Myeloma and Non-Hodgkin’s Lymphoma
por: Lee, Geun Chan, et al.
Publicado: (1994)

Hodgkin lymphoma: flow me?
por: Beaty, Michael W, et al.
Publicado: (2005)

Health-Related Quality of Life in Non-Hodgkin Lymphoma Survivors: A Prospective Cohort Study
por: Kang, Danbee, et al.
Publicado: (2018)

In-depth circulating tumor DNA sequencing for prognostication and monitoring in natural killer/T-cell lymphomas
por: Kim, Jin Ju, et al.
Publicado: (2023)

Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL)
por: Kim, Seok Jin, et al.
Publicado: (2011)

DNA flow cytometric study of 5-fluorouracil used to treat end stage non-Hodgkin's lymphoma.
por: Hedley, D. W.
Publicado: (1987)

Characteristics and outcomes of non-Hodgkin’s lymphoma patients with leptomeningeal metastases
por: Meng, Xiangrui, et al.
Publicado: (2018)

Clinical characteristics, pathological distribution, and prognostic factors in non-Hodgkin lymphoma of Waldeyer's ring: nationwide Korean study
por: Lee, Seong Jun, et al.
Publicado: (2014)

Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas
por: Kim, Seok-Jin, et al.
Publicado: (2019)

BRAF V600E and MAP2K1 Mutations in Hairy Cell Leukemia and Splenic Marginal Zone Lymphoma Cases
por: Shin, Sang-Yong, et al.
Publicado: (2015)

Combined applications of fine needle aspiration cytology and Flow cytometric immunphenotyping for diagnosis and classification of non Hodgkin Lymphoma
por: Dey, Pranab, et al.
Publicado: (2006)

The prophylactic use of lamivudine can maintain dose-intensity of adriamycin in hepatitis-B surface antigen (HBs Ag)-positive patients with Non-Hodgkin's lymphoma who receive cytotoxic chemotherapy.
por: Lee, Gyeong-Won, et al.
Publicado: (2003)

ESHAP Salvage Therapy for Refractory and Relapsed Non-Hodgkin's Lymphoma: A Single Center Experience
por: Park, Sang Hyoung, et al.
Publicado: (2006)

Primary Diffuse Leptomeningeal Gliosarcomatosis
por: Moon, Ju Hyung, et al.
Publicado: (2015)

Lack of usefulness of computed tomography for surveillance in patients with aggressive non-Hodgkin lymphoma
por: Kang, Ka-Won, et al.
Publicado: (2018)

Primary leptomeningeal plasmablastic lymphoma
por: Mathews, Marlon S., et al.
Publicado: (2011)

Autoimmune Hemolytic Anemia in a Patient with Primary Ovarian Non-Hodgkin's Lymphoma
por: Jung, Chang Kil, et al.
Publicado: (2004)

Contribution of 3H-thymidine labelling index and flow cytometric S-phase in predicting survival of patients with non-Hodgkin's lymphoma.
por: Costa, A., et al.
Publicado: (1992)

Differences in mutational signature of diffuse large B‐cell lymphomas according to the primary organ
por: Koh, Hyun‐Hee, et al.
Publicado: (2023)

Neurolymphomatosis of Brachial Plexus in Patients with Non-Hodgkin's Lymphoma
por: Choi, Yong Jun, et al.
Publicado: (2013)

Flow Cytometric Evaluation of Double/Triple Hit Lymphoma
por: Roth, Christine G., et al.
Publicado: (2016)

Clinical impact of CD5 expression in Korean patients with diffuse large B-cell lymphoma
por: Kim, Hyun-Young, et al.
Publicado: (2017)

Clinical relevance of serum-derived exosomal messenger RNA sequencing in patients with non-Hodgkin lymphoma
por: Bang, Yeong Hak, et al.
Publicado: (2022)

Composite follicular lymphoma and classic Hodgkin lymphoma
por: Kim, Han-Na, et al.
Publicado: (2022)

Cerebrospinal fluid metabolomic profiles can discriminate patients with leptomeningeal carcinomatosis from patients at high risk for leptomeningeal metastasis
por: Yoo, Byong Chul, et al.
Publicado: (2017)

Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy
por: Kim, Tark, et al.
Publicado: (2012)

ESHAP salvage therapy for relapsed or refractory non-Hodgkin's lymphoma.
por: Choi, Chul Won, et al.
Publicado: (2002)

Langerhans Cell Histiocytosis Followed by Hodgkin's Lymphoma
por: Park, IK Soo, et al.
Publicado: (2012)

Brentuximab vedotin for relapsed or refractory CD30+ Hodgkin lymphoma: a multicenter analysis from Asia
por: Yang, Qing-Ming, et al.
Publicado: (2014)

Effects of Postoperative Radiotherapy on Leptomeningeal Carcinomatosis or Dural Metastasis after Resection of Brain Metastases in Breast Cancer Patients
por: Ha, Boram, et al.
Publicado: (2017)

Leptomeningeal Seeding in Choroidal Melanoma after Enucleation Surgery
por: Kim, Tae Hwan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jo45uv82i355sd91ihdbmfvuh7